SCHEMBL7008486

SCHEMBL7008486

CCCC(CCC)NC(=O)[N]C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 17/20 0.46
TAS1R1 Q7RTX1 17/20 0.46
HDAC7 Q8WUI4 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
CHRM1 P11229 1/20 0.36
AKR1A1 P14550 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
DRD2 P14416 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3421233 0.75 TAS1R3 (0.52) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL10033481 0.73 TAS1R3 (0.50) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL5133204 0.73 TAS1R3 (0.50) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL9683902 0.71 TAS1R3 (0.48) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL25931497 0.70 TAS1R3 (0.47) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL14521585 0.70 TAS1R3 (0.47) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL965259 0.70
SCHEMBL21157901 0.68 TAS1R3 (0.46) TAS1R3TAS1R1HDAC7HDAC8HDAC6
SCHEMBL965921 0.67
SCHEMBL20914941 0.67 PLA2G2C (0.51) TAS1R3TAS1R1CHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278735-A1 2,4-DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS AstraZeneca AB (SE) 2003-01-29 EP disclosed
WO-2001064656-A1 2,4,DI(HETERO-)ARYLAMINO(-OXY)-5-SUBSTITUTED PYRIMIDINES AS ANTINEOPLASTIC AGENTS ASTRAZENECA AB (SE) 2001-09-07 WO disclosed